Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Codeine-ketamine drug interaction study in healthy volunteers
ACTRN12610000283077Phase 3Active, not recruiting
- Sponsor
- Flinders University
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ketamine and codeine, sponsored by Flinders University. Primary endpoints: Clinically relevant drug-drug interaction between codeine and ketamine and Relationship between opioid metabolism and ketamine. Started Dec 2009; status: active, not recruiting.
02
Drugs
ketaminecodeine
Beyond the preview
Go deeper on ACTRN12610000283077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000283077.